GenMark Diagnostics, Inc. (GNMK)

[Hostile Takeover]

GenMark Diagnostics to raise $28.75 million in public offering
3 days 17 hours 57 minutes ago - DTF via Comtex
Datamonitor Financial Deals Tracker

GenMark Diagnostics, Inc., a US-based developer of diagnostic biomarker detection systems, has filed a registration statement with the US Securities and Exchange Commission to raise approximately $28.75 million in a public offering.

GenMark has granted the underwriters a 30-day option to purchase up to additional shares of its common stock in the public offering to cover any over-allotments, if any.

Canaccord Genuity, Inc. is acting as the sole book-running manager for the offering, while William Blair & Company, LLC is acting as co-lead manager.

Deal Value (US$ Million) 28.75
Deal Type IPO
Sub-Category Secondary Offering
Deal Status Announced: 2011-05-26

Deal Participants

Target (Company) GenMark Diagnostics, Inc.

Deal Rationale

GenMark intends to use the net proceeds to fund acquisitions of complementary businesses, technologies or licenses and to fund for working capital and other general corporate purposes.